Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jan;60(1):91-7.
doi: 10.1211/jpp.60.1.0012.

Glycyrrhizin prevents of lipopolysaccharide/D-galactosamine-induced liver injury through down-regulation of matrix metalloproteinase-9 in mice

Affiliations

Glycyrrhizin prevents of lipopolysaccharide/D-galactosamine-induced liver injury through down-regulation of matrix metalloproteinase-9 in mice

Kazuki Abe et al. J Pharm Pharmacol. 2008 Jan.

Abstract

Glycyrrhizin, a biological active compound isolated from the liquorice root, has been used as a treatment for chronic hepatitis. We have examined the involvement of matrix metalloproteinase (MMP)9 in the development of lipopolysaccharide (LPS) and D-galactosamine (GalN)-induced liver injury in mice. We also investigated the effect of glycyrrhizin on expression of MMP-9 in this model. Levels of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) increased after LPS/ GalN treatment. Expression of MMP-9 mRNA and protein was markedly up-regulated in liver tissues 6-8 h after LPS/GalN treatment. Pretreatment with glycyrrhizin (50 mg kg(-1)) and the MMP inhibitor (5 mg kg(-1)) suppressed increases in serum levels of ALT and AST in mice treated with LPS/GalN. Furthermore, glycyrrhizin inhibited levels of both mRNA and protein for MMP-9. Immunohistochemical reaction for MMP-9 was observed in macrophages/monocytes infiltrated in the inflammatory area of liver injury. Glycyrrhizin reduced the infiltration of inflammatory cells and immunoreactive MMP- 9 in liver injury. The results indicated that MMP-9 played a role in the development of LPS/GalN- induced mouse liver injury, and suggested that an inhibition by glycyrrhizin of the acute liver injury may have been due to a down-regulation of MMP-9.

PubMed Disclaimer

References

    1. Arase, Y. , Ikeda, K. , Murashima, N. , Chayama, K. , Tsubota, A. , Koida, I. , Suzuki, Y. , Saitoh, S. , Kobayashi, M. , Kumada, H. (1997) The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer 79: 1494–1500. - PubMed
    1. Chosay, J. S. , Essani, N. A. , Dunn, C. J. , Jaeschke, H. (1997) Neutrophil margination and extravasation in sinusoids and venules of liver during endotoxin‐induced injury. Am. J. Physiol. 272: G1195–G1200. - PubMed
    1. Cinatl, J. , Morgenstern, B. , Bauer, G. , Chandra, P. , Rabenau, H. , Doerr, H. W. (2003) Glycyrrhizin, an active component of liquorice roots, and replication of SARS‐associated coronavirus. Lancet 361: 2045–2046. - PMC - PubMed
    1. Endo, Y. , Shibazaki, M. , Yamaguchi, K. , Kai, K. , Sugawara, S. , Takada, H. , Kikuchi, H. , Kumagai, K. (1999) Enhancement by galactosamine of lipopolysaccharide (LPS)‐induced tumour necrosis factor production and lethality: its suppression by LPS pretreatment. Br. J. Pharmacol. 128: 5–12. - PMC - PubMed
    1. Ikeda, K. , Arase, Y. , Kobayashi, M. , Saitoh, S. , Someya, T. , Hosaka, T. , Sezaki, H. , Akuta, N. , Suzuki, Y. , Suzuki, F. , Kumada, H. (2006) A long‐term glycyrrhizin injection therapy reduces hepato‐cellular carcinogenesis rate in patients with interferon‐resistant active chronic hepatitis C: a cohort study of 1249 patients. Dig. Dis. Sci. 51: 603–609. - PubMed

MeSH terms